MedTrace Logo

Identification of the UDI-6 and the IIQ-7 Cutoff Scores in Urinary Incontinent Women

NCT04433715 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 155

Last updated 2020-06-16

No results posted yet for this study

Summary

Purpose Urogenital Distress Inventory-6 (UDI-6), Incontinence Impact Questionnaire-7 (IIQ-7) and The International Consultation on Incontinence (ICIQ-SF) Short Form are used to diagnose individuals with urinary incontinence (UI) and to assess the impact of the dysfunction on patient quality of life. While ICIQ-SF has fixed cutoff values - UDI-6 and IIQ-7 do not. We aimed to find the cutoff scores for UDI-6 and IIQ-7 in women with UI.

Methods The study involved 205 women aged between 31 and 83 years - 155 with, and 50 without UI symptoms. All participants completed all three questionnaires: ICIQ-SF, UDI-6 and IIQ-7. Patients were categorized according to their ICIQ-SF scores, as symptomatic ICIQ-SF ≥6 (n=134) and asymptomatic ICIQ \< 6 (n=60). The Receiver Operating Characteristics (ROC) curve was used to test how well UDI-6 allowed a discrimination between patients suffering from UI and those who do not. AUC (Area under Curve) statistic was calculated to measure the UDI-6 and IIQ-7 Total Score efficiency.

Conditions

Interventions

DIAGNOSTIC_TEST

ICIQ-SF

All participants completed ICIQ-SF,

DIAGNOSTIC_TEST

UDI-6

All participants completed UDI-6

DIAGNOSTIC_TEST

IIQ-7

All participants completed IIQ-7

Sponsors & Collaborators

  • Medical University of Lublin

    lead OTHER

Principal Investigators

  • Tomasz Rechberger · Medical University of Lublin

Eligibility

Min Age
31 Years
Max Age
83 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-03-01
Primary Completion
2016-06-30
Completion
2016-07-01

Countries

  • Poland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04433715 on ClinicalTrials.gov